NEW Journal Added! Mucosal Immunology

Posted on by

The Library now has access going back to 2008 to Mucosal Immunology. Mucosal Immunology is the official publication of the Society for Mucosal Immunology and is published by Nature Publishing Group. It aims to provide a forum for both basic and clinical scientists to discuss all aspects of immunity and inflammation involving mucosal tissues.

The Mucosal Immunology journal reflects the interests of scientists studying gastrointestinal, pulmonary, nasopharyngeal, oral, ocular and genitourinary immunology through the publication of original research articles, scholarly reviews and timely commentaries, editorials and letters. The content features basic, translational and clinical studies. Mucosal Immunology also aims to provide a primary method of communication for the SMI governing board and its members through the publication of society news and meeting and conference announcements.

New Drug of Choice for Treatment of Cancer-Associated Venous Thromboembolism (VTE)

Posted on by

It is well known that cancer patients are at a higher risk of developing blood clots. A new randomized clinical trial demonstrated that apixaban, a direct oral anticoagulant (DOAC), was as effective as dalteparin, a low molecular weight heparin given by injection, for the treatment of cancer-associated VTE, without increasing the risk of major bleeding. The study, named the Caravaggio Trial, enrolled 1,170 patients from 119 centers across Europe, the USA, and Israel.

The results were presented by Professor Giancarlo Agnelli at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). The congress was held virtually on March 28-30, 2020. The study was published in the New England Journal of Medicine on March 29, 2020. 

The American Society of Clinical Oncology (ASCO) recently updated (August 2019) its Clinical Practice Guideline for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. Apixaban was included in the updated guideline published in the Journal of Clinical Oncology.